These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 3981090

  • 1. Comparison of RIA kits with polyclonal antiserum and IRMA kits with monoclonal antibodies for the determination of plasma prolactin and somatotropin in patients with pituitary adenoma.
    Oosterom R, Lamberts SW.
    J Clin Chem Clin Biochem; 1985 Jan; 23(1):51-4. PubMed ID: 3981090
    [Abstract] [Full Text] [Related]

  • 2. Serum prolactin and growth hormone determined by radioimmunoassay and a two-site immunoradiometric assay: comparison with the Nb2 cell bioassay.
    Rose DP, Berke B, Cohen LA.
    Horm Metab Res; 1988 Jan; 20(1):49-53. PubMed ID: 3371857
    [Abstract] [Full Text] [Related]

  • 3. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC, Bang F, Laurberg P.
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [Abstract] [Full Text] [Related]

  • 4. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 5. [Radioimmunoassay in the evaluation of the hormonal activity of pituitary adenomas].
    Snigireva RIa, Kasumova SIu, Barabanov VM.
    Med Radiol (Mosk); 1983 Aug; 28(8):16-8. PubMed ID: 6310306
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of IRMA kits using monoclonal antibodies for growth hormone, prolactin and thyrotropin determinations.
    Iacobello C, Malvano R, Dotti C, Vecchi GF, Belloli S, Bonezzi M, Piroddi B, Albertini A.
    J Nucl Med Allied Sci; 1984 Aug; 28(4):271-6. PubMed ID: 6535834
    [No Abstract] [Full Text] [Related]

  • 7. Immunoradiometric assay measurements of insulin-like growth factor-I (IGF-I): comparison with radioimmunoassays using native or des (1-3) IGF-I as radioligands.
    Homayoun P, Daher R, Van Lente F, Faiman C, Gupta MK.
    J Clin Lab Anal; 1996 Aug; 10(6):446-50. PubMed ID: 8951618
    [Abstract] [Full Text] [Related]

  • 8. Immunoradiometric assay for prolactin in serum and tissue--comparison with radioimmunoassay.
    Ohnami S, Nakata H, Eto S.
    Radioisotopes; 1990 Sep; 39(9):393-5. PubMed ID: 2236664
    [Abstract] [Full Text] [Related]

  • 9. [Experimental and clinical studies of a prolactin radioimmunoassay kit].
    Onishi T, Kumahara Y, Fujie T, Ota M, Miyai K.
    Horumon To Rinsho; 1978 Jul; 26(7):711-5. PubMed ID: 668167
    [No Abstract] [Full Text] [Related]

  • 10. Cross-reactivity of monomeric and dimeric biosynthetic human growth hormone in commercial immunoassays.
    Bowsher RR, Apathy JM, Ferguson AL, Riggin RM, Henry DP.
    Clin Chem; 1990 Feb; 36(2):362-6. PubMed ID: 2302782
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas.
    Oppenheim DS, Kana AR, Sangha JS, Klibanski A.
    J Clin Endocrinol Metab; 1990 Apr; 70(4):859-64. PubMed ID: 1690748
    [Abstract] [Full Text] [Related]

  • 12. [Serum human growth hormone assay. Comparison of six assay kits].
    Chabert-Orsini V, Simonin G, Brue T, Conte-Devolx B, Carayon P.
    Ann Endocrinol (Paris); 1992 Apr; 53(4):153-7. PubMed ID: 1305801
    [Abstract] [Full Text] [Related]

  • 13. [Circadian behavior of blood prolactin in patients with pituitary adenoma].
    Murialdo G, Masturzo P, Rolandi E, Barreca T, Perria C.
    Boll Soc Ital Biol Sper; 1978 Feb 15; 54(3):270-3. PubMed ID: 687435
    [No Abstract] [Full Text] [Related]

  • 14. [Endocrine diagnosis of pituitary adenomas (author's transl)].
    Nakai Y, Oki S, Nakao K, Fukada J, Kinoshita F, Tanaka K, Tsukada T, Imura H.
    No To Shinkei; 1981 May 15; 33(5):431-40. PubMed ID: 6266437
    [No Abstract] [Full Text] [Related]

  • 15. Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.
    Ma W, Ikeda H, Yoshimoto T.
    Cancer; 2002 Jul 15; 95(2):258-66. PubMed ID: 12124824
    [Abstract] [Full Text] [Related]

  • 16. Serum gastrin levels in patients with acromegaly.
    Pawlikowski M, Owczarczyk I, Stepień H.
    Horm Metab Res; 1981 Dec 15; 13(12):714-5. PubMed ID: 7319471
    [No Abstract] [Full Text] [Related]

  • 17. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
    Korsisaari N, Ross J, Wu X, Kowanetz M, Pal N, Hall L, Eastham-Anderson J, Forrest WF, Van Bruggen N, Peale FV, Ferrara N.
    Clin Cancer Res; 2008 Jan 01; 14(1):249-58. PubMed ID: 18172277
    [Abstract] [Full Text] [Related]

  • 18. Prolactin and growth hormone in patients with pituitary adenomas: a correlative study of hormone in tumor and plasma by immunoperoxidase technique and radioimmunoassay.
    Zimmerman EA, Defendini R, Frantz AG.
    J Clin Endocrinol Metab; 1974 Apr 01; 38(4):577-85. PubMed ID: 4362395
    [No Abstract] [Full Text] [Related]

  • 19. Molecular heterogeneity of prolactin in the plasma of patients with systemic lupus erythematosus.
    Cruz J, Aviña-Zubieta A, Martínez de la Escalera G, Clapp C, Lavalle C.
    Arthritis Rheum; 2001 Jun 01; 44(6):1331-5. PubMed ID: 11407692
    [Abstract] [Full Text] [Related]

  • 20. Chronobiological study of pituitary adenomas and of the empty sella syndrome.
    Ferrari E, Bossolo PA, Baldi F, Daguati M, Fioravanti M, Facara S.
    Chronobiologia; 1982 Jun 01; 9(2):241-8. PubMed ID: 7117046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.